For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Eyegene Inc.

USPTO Granted Patents = 11

% Expired Patents = 45.5

EPO Patents = 5

Forward Citations = 12

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Yang Je Cho (7 out of 8 patents)

Yang-Je Cho (4 out of 4 patents)

Na Gyong Lee (4 out of 4 patents)

4. Jin-Wook Jang (3 out of 4 patents)

5. Oh-Woong Kwon (3 out of 3 patents)

6. Jin Wook Jang (3 out of 5 patents)

7. Doo Sik Kim (3 out of 4 patents)

8. Won Il Yoo (3 out of 3 patents)

9. Kwangsung Kim (2 out of 2 patents)

10. Doo-Sik Kim (2 out of 9 patents)

11. Hyeong Joon Lim (2 out of 3 patents)

12. Won-Il Yoo (2 out of 2 patents)

13. Soo-Mee Kwon (2 out of 2 patents)

14. Hyeong-Joon Lim (2 out of 2 patents)

15. Bo Young Ahn (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 10918709 - Immune modulator and vaccine composition containing the same (2021-02-16),

2. 10874733 - Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same (2020-12-29),

3. RE48023 - Method for treating vascular-related disease (2020-06-01),

4. 9572877 - Vaccine for inducing an improved immune reaction (2017-02-21),

5. 9566323 - Vaccine for cervical cancer (2017-02-14),

6. 9290542 - Pharmaceutical composition for preventing or treating arteriosclerosis (2016-03-22),

7. 9101581 - Method for treating vascular-related disease (2015-08-11),

8. 8883987 - Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides (2014-11-11),

9. 8372811 - Composition for treating retinopathy or glaucoma comprising thrombin derived peptides (2013-02-12),

10. 7897739 - Method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof (2011-03-01),

11. 7507802 - Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides (2009-03-24),

Eyegene Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of innovative solutions for ocular diseases. The organization focuses on advanced research in gene therapy and regenerative medicine, aiming to address various vision impairments and retinal disorders. By leveraging cutting-edge technologies, Eyegene is committed to enhancing patient outcomes through targeted therapeutic approaches and novel treatment modalities in the field of ophthalmology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#371 in Seoul

#1,009 in South Korea

#51,714 in the World

Seoul, South Korea

Eyegene Inc.

Forward Citations = 12

32 inventors:

Yang Je Cho (7 out of 8 patents)

Yang-Je Cho (4 out of 4 patents)

Na Gyong Lee (4 out of 4 patents)

4. Jin-Wook Jang (3 out of 4 patents)

5. Oh-Woong Kwon (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…